Lachance Group Appears at Egypt International Poultry Exhibition-Agrena 2024

Agrena 2024

From October 10 to 12, 2024, the Egypt International Poultry Exhibition (Agrena 2024) was grandly held at the Cairo International Conference Center. As one of the largest and most prestigious exhibitions for poultry and livestock in the Middle East, Agrena attracted 690 exhibitors and over 62,000 professional visitors from around the world.

In this grand event focused on the poultry and livestock industry, Shandong Longchang Animal Health Products Co., Ltd. (hereinafter referred to as "Lachance Group") became one of the highlights of the exhibition with its innovative products and technologies.

Lachance Group

Founded in 2004, Lachance Group is a high-tech enterprise specializing in the research, development, production, and sales of natural extract additives. The company's vision is to help 6,000 outstanding feed companies and 10 million breeders create wealth safely. It is committed to providing green, antibiotic-free, cost-effective solutions and services.

At Agrena 2024, Lachance Group showcased its main products, including bile acids to improve fat utilization, eucommia leaf extract to help eliminate free radicals, and natural eucalyptus oil from Australia.

Lachance participation not only demonstrated its research and development capabilities in the animal health industry but also reflected the company's further implementation of its internationalization strategy. Its products have already been exported to more than 40 countries and regions, including Egypt, gaining widespread recognition in international markets.

This appearance at Agrena further strengthened Lachance Group connections with clients in the Middle East and Africa, laying a solid foundation for the company's expansion into broader international markets.

Highlights at the Exhibition

At Agrena 2024, Lachance's booth attracted a lot of attention. The company showcased its latest advancements in automated, energy-efficient production processes and equipment, as well as its expertise in bile acid extraction, GMP veterinary drug production, and mixed additive production.

In addition, Lachance's service team shared with visitors the latest findings in the basic and applied research of bile acids, as well as their mechanisms of action and effects on different animals.

The increasing cooperation between China and Egypt has strengthened ties in the animal health sector. Lachance Group participation not only deepened collaboration between the two countries but also provided new opportunities for the company's growth in the Middle East and Africa markets.

Through this exhibition, Lachance Group further consolidated its important position in the global animal health industry and opened a new chapter for its future development.